WallStreetZenWallStreetZen

NASDAQ: CMRX
Chimerix Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for CMRX

Based on 4 analysts offering 12 month price targets for Chimerix Inc

Min Forecast
$6.00-29.58%
Avg Forecast
$8.51-0.08%
Max Forecast
$11.00+29.11%

Should I buy or sell CMRX stock?

Based on 4 analysts offering ratings for Chimerix Inc.

Buy
Strong Buy
0 analysts 0%
Buy
2 analysts 50%
Hold
2 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CMRX stock forecasts and price targets.

CMRX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-03-06
lockedlocked$00.00+00.00%2025-03-05
lockedlocked$00.00+00.00%2025-02-18
lockedlocked$00.00+00.00%2024-11-18

1 of 1

Forecast return on equity

Is CMRX forecast to generate an efficient return?

Company
61.67%
Industry
154.79%
Market
88.2%
CMRX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CMRX forecast to generate an efficient return on assets?

Company
51.4%
Industry
32.71%
CMRX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CMRX earnings per share forecast

What is CMRX's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$0.84
Avg 2 year Forecast
-$0.64
Avg 3 year Forecast
$0.01

CMRX revenue forecast

What is CMRX's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$5.2M+2,366.98%
Avg 2 year Forecast
$53.5M+25,157.55%
Avg 3 year Forecast
$130.8M+61,574.53%
CMRX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CMRX revenue growth forecast

How is CMRX forecast to perform vs Biotechnology companies and vs the US market?

Company
736.49%
Industry
59.84%
Market
10.7%
CMRX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CMRX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CMRX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CMRX$8.52$8.51-0.08%Buy
REPL$10.40$21.50+106.73%Strong Buy
AVXL$9.36$44.00+370.09%Strong Buy
MLYS$16.15$27.00+67.18%Strong Buy
XNCR$11.06$31.25+182.68%Strong Buy
View Top Biotech Stocks

Chimerix Stock Forecast FAQ

Is Chimerix Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: CMRX) stock is to Buy CMRX stock.

Out of 4 analysts, 0 (0%) are recommending CMRX as a Strong Buy, 2 (50%) are recommending CMRX as a Buy, 2 (50%) are recommending CMRX as a Hold, 0 (0%) are recommending CMRX as a Sell, and 0 (0%) are recommending CMRX as a Strong Sell.

If you're new to stock investing, here's how to buy Chimerix stock.

What is CMRX's earnings growth forecast for 2025-2027?

(NASDAQ: CMRX) Chimerix's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.99%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.81%.

Chimerix's earnings in 2025 is -$88,387,000.On average, 4 Wall Street analysts forecast CMRX's earnings for 2025 to be -$78,326,211, with the lowest CMRX earnings forecast at -$108,812,461, and the highest CMRX earnings forecast at -$7,504,308. On average, 4 Wall Street analysts forecast CMRX's earnings for 2026 to be -$60,034,461, with the lowest CMRX earnings forecast at -$88,175,615, and the highest CMRX earnings forecast at -$23,450,962.

In 2027, CMRX is forecast to generate $469,019 in earnings, with the lowest earnings forecast at -$10,318,423 and the highest earnings forecast at $11,256,462.

What is CMRX's revenue growth forecast for 2025-2027?

(NASDAQ: CMRX) Chimerix's forecast annual revenue growth rate of 736.49% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 59.84%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.7%.

Chimerix's revenue in 2025 is $212,000.On average, 3 Wall Street analysts forecast CMRX's revenue for 2025 to be $490,594,115, with the lowest CMRX revenue forecast at $35,645,461, and the highest CMRX revenue forecast at $844,234,614. On average, 3 Wall Street analysts forecast CMRX's revenue for 2026 to be $5,022,820,738, with the lowest CMRX revenue forecast at $2,208,142,535, and the highest CMRX revenue forecast at $9,239,678,831.

In 2027, CMRX is forecast to generate $12,264,852,865 in revenue, with the lowest revenue forecast at $7,139,410,719 and the highest revenue forecast at $17,390,295,010.

What is CMRX's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: CMRX) forecast ROA is 51.4%, which is higher than the forecast US Biotechnology industry average of 32.71%.

What is CMRX's Price Target?

According to 4 Wall Street analysts that have issued a 1 year CMRX price target, the average CMRX price target is $8.51, with the highest CMRX stock price forecast at $11.00 and the lowest CMRX stock price forecast at $6.00.

On average, Wall Street analysts predict that Chimerix's share price could fall to $8.51 by Mar 6, 2026. The average Chimerix stock price prediction forecasts a potential downside of 0.08% from the current CMRX share price of $8.52.

What is CMRX's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: CMRX) Chimerix's current Earnings Per Share (EPS) is -$0.99. On average, analysts forecast that CMRX's EPS will be -$0.84 for 2025, with the lowest EPS forecast at -$1.16, and the highest EPS forecast at -$0.08. On average, analysts forecast that CMRX's EPS will be -$0.64 for 2026, with the lowest EPS forecast at -$0.94, and the highest EPS forecast at -$0.25. In 2027, CMRX's EPS is forecast to hit $0.01 (min: -$0.11, max: $0.12).

What is CMRX's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: CMRX) forecast ROE is 61.67%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.